Trials / Recruiting
RecruitingNCT06551129
Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Real-World Camzyos Patient Reported OutcoMes Through PAtient SurveyS in Hypertrophic CardioMyopathy (COMPASS-HCM): A Prospective Longitudinal Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 118 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This real-world study will assess changes in health status among participants with symptomatic obstructive hypertrophic cardiomyopathy who are treated with mavacamten in the real world.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | As prescribed by treating physician |
Timeline
- Start date
- 2024-05-10
- Primary completion
- 2026-12-31
- Completion
- 2027-06-30
- First posted
- 2024-08-13
- Last updated
- 2024-11-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06551129. Inclusion in this directory is not an endorsement.